We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $107M
1-Year Est. Return 82.62%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+82.62%
3 Year Est. Return
+219.47%
5 Year Est. Return
+202.9%
10 Year Est. Return
AUM
$120M
AUM Growth
+$2.85M
Cap. Flow
+$68.8K
Cap. Flow %
0.06%
Top 10 Hldgs %
41.03%
Holding
96
New
4
Increased
14
Reduced
31
Closed
6

Sector Composition

1 Healthcare 51.19%
2 Technology 27.98%
3 Industrials 7.93%
4 Communication Services 5.39%
5 Consumer Staples 4.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.06T
$9.83M 8.2%
12,637
-130
-1% -$92.5K
MSFT icon
2
Microsoft
MSFT
$2.89T
$6.36M 5.31%
15,126
-200
-1% -$81K
AUGX
3
DELISTED
Augmedix, Inc. Common Stock
AUGX
$5.96M 4.97%
1,458,268
-6,300
-0.4% -$28.2K
IDXX icon
4
Idexx Laboratories
IDXX
$44.7B
$5.67M 4.73%
10,500
NTRA icon
5
Natera
NTRA
$37.9B
$5.5M 4.59%
60,125
-1,750
-3% -$132K
AMD icon
6
Advanced Micro Devices
AMD
$790B
$4.07M 3.39%
22,554
-550
-2% -$96.1K
QUIK icon
7
QuickLogic
QUIK
$227M
$3.31M 2.76%
206,606
-16,000
-7% -$230K
NEO icon
8
NeoGenomics
NEO
$1.87B
$3.04M 2.53%
193,200
ABT icon
9
Abbott
ABT
$176B
$2.88M 2.41%
25,380
VCYT icon
10
Veracyte
VCYT
$4.63B
$2.57M 2.14%
115,980
-1,200
-1% -$29.3K
ATEC icon
11
Alphatec Holdings
ATEC
$1.33B
$2.54M 2.12%
184,267
-600
-0.3% -$8.9K
ELUT icon
12
Elutia
ELUT
$40.2M
$2.51M 2.09%
797,602
+19,100
+2% +$66.3K
AXGN icon
13
Axogen
AXGN
$2.07B
$2.4M 2%
297,949
-1,666
-0.6% -$14.9K
INUV icon
14
Inuvo
INUV
$19.2M
$2.4M 2%
702,346
-2,000
-0.3% -$8.38K
LMAT icon
15
LeMaitre Vascular
LMAT
$2.32B
$2.34M 1.95%
35,301
DGII icon
16
Digi International
DGII
$2.38B
$2.29M 1.91%
71,833
+500
+0.7% +$14K
AIRG icon
17
Airgain
AIRG
$76.9M
$2.04M 1.71%
375,150
-4,670
-1% -$19.8K
USIO icon
18
Usio Inc
USIO
$58.5M
$1.77M 1.48%
1,042,693
+2,000
+0.2% +$3.42K
PFIE
19
DELISTED
Profire Energy, Inc
PFIE
$1.75M 1.46%
945,520
+8,788
+0.9% +$13.9K
CTLP
20
DELISTED
Cantaloupe
CTLP
$1.65M 1.37%
256,100
-5,000
-2% -$33K
FPAY
21
DELISTED
FlexShopper
FPAY
$1.64M 1.37%
1,101,943
-113,850
-9% -$147K
VCEL icon
22
Vericel Corp
VCEL
$2.39B
$1.63M 1.36%
31,250
MRK icon
23
Merck
MRK
$324B
$1.61M 1.35%
12,225
ABBV icon
24
AbbVie
ABBV
$457B
$1.55M 1.29%
8,508
-650
-7% -$112K
AKTS
25
DELISTED
Akoustis Technologies Inc
AKTS
$1.42M 1.19%
2,405,152
+1,798,500
+296% +$1.16M

Similar funds

Perkins Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Perkins Capital Management held 96 positions worth $120M, up 2.4% from $117M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Perkins Capital Management's Q1 2024 filing shows 4 new, 14 increased, 31 reduced and 6 closed positions. Its largest new stake was ConocoPhillips: 8,000 shares worth $1.02M. The largest sale was Patterson Companies, Inc., an estimated $767K.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 50% a quarter earlier, followed by Technology and Industrials.

  • Perkins Capital Management's largest Q1 2024 buy was ConocoPhillips: 8,000 shares worth $1.02M.
  • Perkins Capital Management added most to Akoustis Technologies Inc in Q1 2024, an estimated $1.16M increase.
  • Perkins Capital Management's biggest Q1 2024 reduction was BioLife Solutions, cutting an estimated $306K.
  • Perkins Capital Management fully exited Patterson Companies, Inc. in Q1 2024, selling an estimated $767K.
  • Perkins Capital Management's ten largest holdings make up 41% of its $120M portfolio in Q1 2024.
  • Perkins Capital Management opened 4 new positions and closed 6 in Q1 2024.
  • Perkins Capital Management's portfolio value rose 2.4% quarter-over-quarter to $120M.

Based on Perkins Capital Management's 13F filing for Q1 2024, filed 9 May 2024.